tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
Germany Market
Advertisement

Infant Bacterial Therapeutics AB (9IB) Income Statement

Compare
4 Followers

Infant Bacterial Therapeutics AB Income Statement

Last quarter (Q1 2025), Infant Bacterial Therapeutics AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q1, Infant Bacterial Therapeutics AB's net income was kr-16.74M. See Infant Bacterial Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 77.00Kkr 12.00Kkr 0.00kr 0.00
Gross Profit
kr 0.00kr 77.00Kkr 12.00Kkr 0.00kr 0.00
Operating Expenses
kr 139.90Mkr 134.69Mkr 65.81Mkr 44.58Mkr 71.92M
Depreciation and Amortization
kr 0.00kr 134.62Mkr 816.00Kkr 816.00Kkr 816.00K
EBITDA
kr -136.91Mkr 11.55Mkr -65.45Mkr -44.99Mkr -72.01M
Operating Income
kr -139.90Mkr -134.62Mkr -65.81Mkr -44.58Mkr -71.92M
Other Income/Expenses
kr 3.00Mkr 11.55Mkr 357.00Kkr -413.00Kkr -89.00K
Pretax Income
kr -136.91Mkr -123.07Mkr -65.45Mkr -44.99Mkr -72.01M
Net Income
kr -136.91Mkr -123.07Mkr -65.09Mkr -45.40Mkr -72.31M
Per Share Metrics
Basic EPS
kr -10.16kr -9.95kr -5.80kr -4.04kr -6.44
Diluted EPS
kr -10.16kr -9.95kr -5.80kr -4.04kr -6.44
Weighted Average Shares Outstanding
13.47M 12.36M 11.23M 11.23M 11.23M
Weighted Average Shares Outstanding (Diluted)
13.47M 12.36M 11.23M 11.23M 11.23M
Currency in SEK

Infant Bacterial Therapeutics AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis